Table 1. Baseline patient... | American Society of Hematology

Table 1.

Baseline patient characteristics

Patient no.	Age, y	Sex	Time from Dx to Bx, d	Site of Bx	Prior therapy before Bx	Time from Dx to last FU, y	Response at last FU	Death
1	88	M	48	Spleen	N	0.9	Prog	Y
2	80	F	0	LN	N	1.8	PR	N
3	71	F	559	LN	Y	3.4	PR	N
4	51	M	2263	LN	Y	9.8	Secondary AML	Y
5	59	F	214	LN	N	1.8	CR	N
6	64	M	0	LN	N	0.7	Stable	N
7	74	M	2063	LN	Y	6.6	Prog	Y

Patient no.	Age, y	Sex	Time from Dx to Bx, d	Site of Bx	Prior therapy before Bx	Time from Dx to last FU, y	Response at last FU	Death
1	88	M	48	Spleen	N	0.9	Prog	Y
2	80	F	0	LN	N	1.8	PR	N
3	71	F	559	LN	Y	3.4	PR	N
4	51	M	2263	LN	Y	9.8	Secondary AML	Y
5	59	F	214	LN	N	1.8	CR	N
6	64	M	0	LN	N	0.7	Stable	N
7	74	M	2063	LN	Y	6.6	Prog	Y

Dx indicates diagnosis; Bx, biopsy; FU, follow-up; Prog, progression; LN, lymph node; PR, partial remission; AML, acute myeloid leukemia; and CR, complete remission.

View Large

This Feature Is Available To Subscribers Only